Seth Klarman - Baupost Group
Holding/activity history for Keryx Biopharmaceuticals Inc (KERX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.69 | SEC | ||
| 2018 Q3 | 25,791,678 | 0.69 | $3.40 | $87,692,000 | SEC | ||
| 2018 Q2 | 25,791,678 | 0.87 | $3.76 | $96,977,000 | SEC | ||
| 2018 Q1 | 25,791,678 | 1.03 | $4.09 | $105,488,000 | SEC | ||
| 2017 Q4 | 25,791,678 | 1.19 | $4.65 | $119,931,000 | SEC | ||
| 2017 Q3 | 25,791,678 | 2.33 | $7.10 | $183,121,000 | SEC | ||
| 2017 Q2 | 25,791,678 | 2.23 | $7.23 | $186,474,000 | SEC | ||
| 2017 Q1 | 25,791,678 | 1.93 | $6.16 | $158,877,000 | SEC | ||
| 2016 Q4 | 25,791,678 | 2.02 | $5.86 | $151,139,000 | SEC | ||
| 2016 Q3 | 25,791,678 | 2.02 | $5.31 | $136,954,000 | SEC | ||
| 2016 Q2 | 25,791,678 | 2.39 | $6.62 | $170,741,000 | SEC | ||
| 2016 Q1 | 25,791,678 | 1.78 | $4.67 | $120,447,000 | SEC | ||
| 2015 Q4 | 25,791,678 | 2.56 | $5.05 | $130,248,000 | SEC | ||
| 2015 Q3 | 25,791,678 | 1.51 | $3.28 | $84,522,000 | SEC | ||
| 2015 Q2 | 25,791,678 | 4.88 | Add 15.24% | 0.65 | $9.98 | $257,401,000 | SEC |
| 2015 Q1 | 22,380,200 | 5.24 | Add 22.30% | 0.96 | $12.73 | $284,900,000 | SEC |
| 2014 Q4 | 18,300,000 | 5.56 | $14.15 | $258,945,000 | SEC | ||
| 2014 Q3 | 18,300,000 | 4.69 | Add 73.62% | 1.99 | $13.75 | $251,625,000 | SEC |
| 2014 Q2 | 10,539,986 | 2.94 | Add 67.01% | 1.18 | $15.38 | $162,105,000 | SEC |
| 2014 Q1 | 6,310,850 | 3.10 | Buy | 3.10 | $17.04 | $107,537,000 | SEC |